Cardinal Capital Management Novo Nordisk A S Transaction History

Cardinal Capital Management

  • $582 Million
  • Q2 2024

A detailed history of Cardinal Capital Management transactions in Novo Nordisk A S stock. As of the latest transaction made, Cardinal Capital Management holds 48,312 shares of NVO stock, worth $5.63 Million. This represents 1.18% of its overall portfolio holdings.

Number of Shares
48,312
Previous 68,729 29.71%
Holding current value
$5.63 Million
Previous $8.82 Million 21.85%
% of portfolio
1.18%
Previous 1.45%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024
SELL
$122.71 - $146.91 $2.51 Million - $3 Million
-20,417 Reduced 29.71%
48,312 $6.9 Million
Q1 2024

Jul 12, 2024
BUY
$102.11 - $135.92 $145,200 - $193,278
1,422 Added 2.11%
68,729 $8.82 Million
Q1 2024

Apr 15, 2024
BUY
$102.11 - $135.92 $145,200 - $193,278
1,422 Added 2.11%
68,729 $8.82 Million
Q4 2023

Jul 12, 2024
SELL
$87.78 - $105.45 $67,766 - $81,407
-772 Reduced 1.13%
67,307 $6.96 Million
Q4 2023

Jan 26, 2024
SELL
$87.78 - $105.45 $67,766 - $81,407
-772 Reduced 1.13%
67,307 $6.96 Million
Q3 2023

Jul 12, 2024
BUY
$90.94 - $199.54 $3.11 Million - $6.82 Million
34,166 Added 100.75%
68,079 $6.19 Million
Q3 2023

Oct 16, 2023
BUY
$90.94 - $199.54 $3.11 Million - $6.82 Million
34,166 Added 100.75%
68,079 $6.19 Million
Q2 2023

Jul 12, 2024
SELL
$155.98 - $172.65 $5.43 Million - $6.01 Million
-34,816 Reduced 50.66%
33,913 $5.49 Million
Q2 2023

Jul 12, 2023
SELL
$155.98 - $172.65 $83,605 - $92,540
-536 Reduced 1.56%
33,913 $5.49 Million
Q1 2023

Apr 18, 2023
SELL
$132.34 - $159.14 $52,141 - $62,701
-394 Reduced 1.13%
34,449 $5.48 Million
Q4 2022

Jan 20, 2023
SELL
$102.55 - $135.33 $54,556 - $71,995
-532 Reduced 1.5%
34,843 $0
Q3 2022

Oct 21, 2022
SELL
$95.28 - $116.93 $56,119 - $68,871
-589 Reduced 1.64%
35,375 $3.52 Million
Q2 2022

Aug 04, 2022
BUY
$103.24 - $121.81 $6,607 - $7,795
64 Added 0.18%
35,964 $4.01 Million
Q1 2022

Apr 21, 2022
BUY
$93.1 - $112.54 $67,776 - $81,929
728 Added 2.07%
35,900 $3.99 Million
Q4 2021

Jan 18, 2022
SELL
$95.88 - $117.08 $21,477 - $26,225
-224 Reduced 0.63%
35,172 $3.94 Million
Q3 2021

Oct 21, 2021
SELL
$84.42 - $106.62 $19,501 - $24,629
-231 Reduced 0.65%
35,396 $3.4 Million
Q2 2021

Jul 14, 2021
BUY
$67.66 - $84.76 $17,320 - $21,698
256 Added 0.72%
35,627 $2.98 Million
Q1 2021

Apr 19, 2021
BUY
$67.06 - $75.82 $23,538 - $26,612
351 Added 1.0%
35,371 $2.39 Million
Q4 2020

Feb 01, 2021
BUY
$63.89 - $73.8 $30,731 - $35,497
481 Added 1.39%
35,020 $2.45 Million
Q3 2020

Oct 16, 2020
BUY
$63.69 - $70.22 $4,203 - $4,634
66 Added 0.19%
34,539 $2.4 Million
Q2 2020

Jul 16, 2020
SELL
$58.54 - $67.94 $314,301 - $364,769
-5,369 Reduced 13.48%
34,473 $2.26 Million
Q1 2020

Apr 20, 2020
SELL
$49.46 - $64.78 $25,372 - $33,232
-513 Reduced 1.27%
39,842 $2.4 Million
Q4 2019

Jan 21, 2020
SELL
$49.86 - $58.26 $15,207 - $17,769
-305 Reduced 0.75%
40,355 $2.34 Million
Q3 2019

Oct 18, 2019
BUY
$47.54 - $53.43 $2,139 - $2,404
45 Added 0.11%
40,660 $2.1 Million
Q2 2019

Jul 08, 2019
SELL
$46.79 - $52.47 $31,676 - $35,522
-677 Reduced 1.64%
40,615 $2.07 Million
Q1 2019

Apr 11, 2019
BUY
$46.36 - $52.63 $10,940 - $12,420
236 Added 0.57%
41,292 $2.16 Million
Q4 2018

Jan 15, 2019
BUY
$41.54 - $47.25 $32,733 - $37,233
788 Added 1.96%
41,056 $1.89 Million
Q3 2018

Oct 25, 2018
BUY
$46.76 - $51.24 $9,352 - $10,248
200 Added 0.5%
40,268 $1.9 Million
Q2 2018

Jul 25, 2018
BUY
$44.29 - $50.42 $29,895 - $34,033
675 Added 1.71%
40,068 $1.85 Million
Q1 2018

Apr 25, 2018
BUY
$48.49 - $58.14 $9,698 - $11,628
200 Added 0.51%
39,393 $1.94 Million
Q4 2017

Feb 01, 2018
BUY
$47.53 - $53.73 $13,023 - $14,722
274 Added 0.7%
39,193 $2.1 Million
Q3 2017

Oct 24, 2017
BUY
$41.15 - $49.22 $1.6 Million - $1.92 Million
38,919
38,919 $1.87 Million

Others Institutions Holding NVO

# of Institutions
1,990
Shares Held
318M
Call Options Held
5.23M
Put Options Held
4.97M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $263B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Cardinal Capital Management Portfolio

Follow Cardinal Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cardinal Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Cardinal Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email